Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner.
Improvements in surgical technique and the introduction of several new immunosuppressive medications mean that outcome after orthotopic liver transplantation (OLT) has improved continuously over the past 15 years. Given the increasing longevity of patients after OLT, the recognition and prevention of long-term complications after transplantation have become ever more important. With respect to graft function, physicians responsible for the everyday care of patients following transplantation should be particularly aware of the risk of late and chronic rejection episodes and of recurrence of the underlying liver disease. The major challenge of post-transplant care is, however, how best to prevent and manage the long-term adverse effects caused by the immunosuppressive medications prescribed. Screening investigations for early diagnosis of malignancy, strict control of cardiovascular risk factors, preservation of renal function, and prevention of infections are, therefore, fundamental. This Review suggests guidelines for the management of OLT recipients to improve long-term survival, overall outcome and health-related quality of life.
Benten
Daniel
D
Department of Gastroenterology/Hepatology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Staufer
Katharina
K
Sterneck
Martina
M
D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016031:Liver Transplantation / Q000276:immunology; D017063:Outcome Assessment, Health Care; D010821:Physicians, Family; D011182:Postoperative Care; D011183:Postoperative Complications / Q000517:prevention & control*; D011788:Quality of Life
D007166:Immunosuppressive Agents